H. Prais

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

D. Bhatnagar, D Bhatnagar, P. Durrington, 1999, The Lancet.

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins.

P. Winocour, P. Durrington, D. Bhatnagar, 1992, Atherosclerosis.

Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease.

P. Durrington, D. Bhatnagar, M. Mackness, 1993, Atherosclerosis.

Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.

D. Bhatnagar, M. Mackness, P. Durrington, 1994, European journal of clinical nutrition.

Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.

R. Gokal, D. Bhatnagar, M. Mackness, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.

P. Durrington, D. Bhatnagar, M. Mackness, 1998, Atherosclerosis.

Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy

P. McElduff, A. Yates, I. Laing, 2004, Clinical endocrinology.

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double‐blind placebo‐controlled trial of high‐ vs. low‐dose atorvastatin 1

M. Gittins, P. Durrington, V. Charlton-Menys, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Methods for the prediction of coronary heart disease risk

P. Durrington, H. Prais, 2001, Heart.